SP 903-2026 Acquisition of Morphine [10 mg/1ml; Epidural-Intrathecal; and Others, F./Amp.] (AQ 2024-898)

This tender, identified as SP 903-2026 and linked to procurement reference AQ 2024-898, concerns the acquisition of Morphine. Specifically, it requests Morphine in a 10 mg/1ml concentration, suitable for epidural and intrathecal administration, as well as other formulations presented in vials/ampoules (F./Amp.). Morphine is a potent opioid analgesic used for managing moderate to severe pain. The objective is to secure a supply of this essential medication for pain management purposes, particularly for procedures requiring specific routes of administration like epidural or intrathecal injections. The tender will detail the required quantities, packaging specifications, quality standards (e.g., pharmaceutical grade), and delivery requirements. Bidders must comply with all pharmaceutical regulations and demonstrate their ability to provide this controlled substance safely and reliably. This procurement is critical for effective pain relief in clinical settings.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 4,960.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.